文献速递毛发、甲与色素性疾病

枯草芽孢杆菌胞外多糖在白癜风小鼠模型中阻止脱色与自身免疫

Bacillus Subtilis-Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in Vitiligo.
PubMed 文献 · J Invest Dermatol · 2024-12-31

本研究在白癜风倾向的h3TA2小鼠中测试枯草芽孢杆菌来源的胞外多糖(EPS)作为微生物组疗法。每周腹腔注射EPS共18周,EPS显著减缓脱色速度,减少皮肤CD8+细胞毒性T细胞并增加调节性T细胞,同时诱导脾脏M2巨噬细胞增多、IDO表达升高及Th2型细胞因子偏移,脾细胞对酪氨酸酶肽反应减弱。提示EPS可能成为白癜风新型治疗实体。

要点

  • EPS腹腔注射18周显著减缓h3TA2小鼠脱色速度
  • EPS减少皮肤CD8+T细胞、增加调节性T细胞
  • EPS诱导脾M2巨噬细胞和IDO升高及Th2偏移

核心结论

  • 枯草芽孢杆菌来源EPS在h3TA2小鼠模型中干扰T细胞介导的脱色,提示其可能作为白癜风新型治疗实体。

研究设计与样本

  • 研究使用白癜风倾向的h3TA2小鼠,每周腹腔注射EPS共18周,动态评估脱色并在终点检测免疫反应。

主要发现

  • EPS治疗显著限制脱色速度。
  • EPS治疗减少皮肤T细胞尤其是CD8+细胞毒性T细胞丰度,并增加调节性T细胞。
  • EPS治疗增加脾脏M2巨噬细胞数量、升高脾脏IDO表达并促使全身细胞因子向2型模式偏移。
  • EPS处理小鼠的脾细胞对同源酪氨酸酶肽反应减弱,表现为IFN-γ及其他炎症因子释放受限。

临床怎么用

  • EPS作为微生物组来源的候选疗法,可能通过调节T细胞平衡和诱导免疫耐受途径干预白癜风进展。

局限性

  • 证据来自h3TA2小鼠模型,尚未在人体中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitiligo has a complex multifactorial etiology involving a T-cell-mediated autoimmune response to cutaneous melanocytes. Microbial dysbiosis has been assigned a contributing role in vitiligo etiology. Treating vitiligo can be a challenging task, and finding novel treatment approaches is crucial. In this study, we tested exopolysaccharides (EPSs) isolated from Bacillus subtilis as a microbiome-based therapy. Vitiligo-prone h3TA2 mice were treated by weekly intraperitoneal EPS injection for 18 weeks. Depigmentation was evaluated over time, measuring immune responses at end point. EPS treatment significantly limited the rate of depigmentation. The abundance of cutaneous T cells, specifically CD8+ cytotoxic T cells, was reduced, whereas regulatory T cells were more abundant in the skin of treated mice than in untreated mice. Moreover, EPS treatment was associated with increased numbers of splenic M2 macrophages, elevated splenic indoleamine 2,3-dioxygenase expression, and a systemic cytokine shift toward a type 2 pattern of cytokines. Importantly, splenocytes retrieved from EPS-treated mice were less responsive to cognate tyrosinase peptide, as demonstrated by limited release of IFN-γ and other inflammatory cytokines. In summary, EPS isolated from Bsubtilis interfered with T-cell-mediated depigmentation in the h3TA2 mouse model of vitiligo, suggesting that Bsubtilis EPS could serve as a novel treatment entity for vitiligo.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Touni AA, Muttar S, Siddiqui Z, et al. Bacillus Subtilis-Derived Exopolysaccharide Halts Depigmentation and Autoimmunity in Vitiligo. J Invest Dermatol. 2024. PMID: 39746569. doi:10.1016/j.jid.2024.12.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。